These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24800948)
21. Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair. Alex AK; Siqueira S; Coudry R; Santos J; Alves M; Hoff PM; Riechelmann RP Clin Colorectal Cancer; 2017 Sep; 16(3):228-239. PubMed ID: 28063788 [TBL] [Abstract][Full Text] [Related]
22. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases. Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475 [TBL] [Abstract][Full Text] [Related]
23. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer. Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739 [TBL] [Abstract][Full Text] [Related]
24. Correlations between expression levels of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase, and efficacy of 5-fluorouracil-based chemotherapy for advanced colorectal cancer. Bai W; Wu Y; Zhang P; Xi Y Int J Clin Exp Pathol; 2015; 8(10):12333-45. PubMed ID: 26722420 [TBL] [Abstract][Full Text] [Related]
25. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas. Wang J; Li R; He Y; Yi Y; Wu H; Liang Z Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917 [TBL] [Abstract][Full Text] [Related]
26. Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine. Uchida K; Danenberg PV; Danenberg KD; Grem JL BMC Cancer; 2008 Dec; 8():386. PubMed ID: 19105824 [TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression. Jensen SA; Vainer B; Kruhøffer M; Sørensen JB BMC Cancer; 2009 Jan; 9():25. PubMed ID: 19154585 [TBL] [Abstract][Full Text] [Related]
28. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine. Ma T; Zhu ZG; Ji YB; Zhang Y; Yu YY; Liu BY; Yin HR; Lin YZ World J Gastroenterol; 2004 Jan; 10(2):172-6. PubMed ID: 14716816 [TBL] [Abstract][Full Text] [Related]
29. Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis. Vallböhmer D; Kuramochi H; Shimizu D; Danenberg KD; Lindebjerg J; Nielsen JN; Jakobsen A; Danenberg PV Int J Oncol; 2006 Feb; 28(2):527-33. PubMed ID: 16391809 [TBL] [Abstract][Full Text] [Related]
30. Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision. Donada M; Bonin S; Barbazza R; Pettirosso D; Stanta G BMC Gastroenterol; 2013 Feb; 13():36. PubMed ID: 23446022 [TBL] [Abstract][Full Text] [Related]
31. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Koopman M; Kortman GA; Mekenkamp L; Ligtenberg MJ; Hoogerbrugge N; Antonini NF; Punt CJ; van Krieken JH Br J Cancer; 2009 Jan; 100(2):266-73. PubMed ID: 19165197 [TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy. Li JY; Park HS; Huang GS; Young MR; Ratner E; Santin A; Damast S Gynecol Oncol; 2021 Dec; 163(3):557-562. PubMed ID: 34602287 [TBL] [Abstract][Full Text] [Related]
34. Relevance of dihydropyrimidine-dehydrogenase and thymidylate-synthase in patients with pancreatic neuroendocrine neoplasms treated with 5-FU-based chemotherapy. Krug S; Boch M; Nimphius W; Gress TM; Michl P; Rinke A Pancreatology; 2017; 17(1):139-145. PubMed ID: 28027897 [TBL] [Abstract][Full Text] [Related]
35. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations. Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813 [TBL] [Abstract][Full Text] [Related]
36. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil. Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586 [TBL] [Abstract][Full Text] [Related]
37. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy. Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211 [TBL] [Abstract][Full Text] [Related]
38. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer. Meropol NJ; Gold PJ; Diasio RB; Andria M; Dhami M; Godfrey T; Kovatich AJ; Lund KA; Mitchell E; Schwarting R J Clin Oncol; 2006 Sep; 24(25):4069-77. PubMed ID: 16943524 [TBL] [Abstract][Full Text] [Related]
39. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine. Tokunaga Y; Takahashi K; Saito T Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy. Jakob C; Liersch T; Meyer W; Baretton GB; Schwabe W; Häusler P; Kulle B; Becker H; Aust DE Am J Surg Pathol; 2006 Sep; 30(9):1169-74. PubMed ID: 16931962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]